Fort Washington Investment Advisors Inc. OH Has $18.46 Million Stock Holdings in Doximity, Inc. $DOCS

Fort Washington Investment Advisors Inc. OH boosted its position in shares of Doximity, Inc. (NYSE:DOCS) by 73.5% during the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 792,191 shares of the company’s stock after acquiring an additional 335,490 shares during the period. Fort Washington Investment Advisors Inc. OH’s holdings in Doximity were worth $18,458,000 at the end of the most recent quarter.

A number of other hedge funds also recently modified their holdings of the company. Vanguard Group Inc. lifted its position in Doximity by 4.1% in the fourth quarter. Vanguard Group Inc. now owns 13,285,485 shares of the company’s stock worth $588,281,000 after purchasing an additional 518,916 shares during the period. UBS Group AG increased its holdings in Doximity by 26.5% in the 4th quarter. UBS Group AG now owns 680,260 shares of the company’s stock valued at $30,122,000 after buying an additional 142,408 shares during the period. Northwestern Mutual Wealth Management Co. increased its holdings in Doximity by 325,436.6% in the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 1,298,891 shares of the company’s stock valued at $57,515,000 after buying an additional 1,298,492 shares during the period. Blair William & Co. IL raised its stake in shares of Doximity by 1,990.7% in the 3rd quarter. Blair William & Co. IL now owns 362,740 shares of the company’s stock valued at $26,534,000 after buying an additional 345,390 shares in the last quarter. Finally, William Blair Investment Management LLC raised its stake in shares of Doximity by 11.7% in the 3rd quarter. William Blair Investment Management LLC now owns 5,829,169 shares of the company’s stock valued at $426,404,000 after buying an additional 609,775 shares in the last quarter. Institutional investors own 87.19% of the company’s stock.

Analysts Set New Price Targets

Several analysts have recently weighed in on DOCS shares. JPMorgan Chase & Co. decreased their target price on shares of Doximity from $33.00 to $28.00 and set a “neutral” rating on the stock in a research report on Thursday, May 14th. Barclays reissued an “equal weight” rating and issued a $20.00 price target (down from $38.00) on shares of Doximity in a research report on Thursday, May 14th. Freedom Capital upgraded shares of Doximity to a “strong-buy” rating in a research note on Tuesday, March 17th. Leerink Partners dropped their target price on Doximity from $31.00 to $25.00 and set an “outperform” rating for the company in a report on Thursday, May 14th. Finally, BMO Capital Markets decreased their price target on Doximity from $25.00 to $20.00 and set a “market perform” rating on the stock in a research note on Thursday, May 14th. Two investment analysts have rated the stock with a Strong Buy rating, seven have given a Buy rating, twelve have assigned a Hold rating and two have assigned a Sell rating to the stock. According to MarketBeat, the company has a consensus rating of “Hold” and an average target price of $30.62.

Insiders Place Their Bets

In other Doximity news, Director Kira Scherer Wampler sold 9,000 shares of the business’s stock in a transaction dated Thursday, May 7th. The stock was sold at an average price of $26.06, for a total transaction of $234,540.00. Following the completion of the sale, the director directly owned 19,839 shares of the company’s stock, valued at approximately $517,004.34. The trade was a 31.21% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Siddharth Sitaram sold 2,444 shares of the company’s stock in a transaction on Monday, June 8th. The shares were sold at an average price of $20.41, for a total transaction of $49,882.04. Following the sale, the insider owned 90,706 shares of the company’s stock, valued at $1,851,309.46. The trade was a 2.62% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders have sold a total of 16,180 shares of company stock valued at $395,110 over the last ninety days. Insiders own 31.30% of the company’s stock.

Doximity Stock Down 0.3%

NYSE:DOCS opened at $20.81 on Monday. The company has a market capitalization of $3.81 billion, a PE ratio of 21.02, a P/E/G ratio of 3.55 and a beta of 1.30. Doximity, Inc. has a 1 year low of $17.15 and a 1 year high of $76.51. The firm has a 50 day moving average price of $21.92.

About Doximity

Doximity, trading as DOCS, operates a digital professional network and communications platform designed primarily for clinicians. Headquartered in San Francisco, the company connects physicians, nurse practitioners, physician assistants and other healthcare professionals, providing tools that streamline clinical communication, telehealth delivery and access to specialty-specific medical information. Its platform is positioned as a professional hub where clinicians manage their workflows, stay current with medical news and collaborate securely with peers.

The company’s offerings include secure messaging and video telehealth capabilities that enable clinicians to consult with patients and colleagues while protecting patient information.